COVID-19 Forum, Information, Studies, Treatments

COVID-19 Coronavirus => COVID-19 Later Stage Hospital Studies and Trials => Topic started by: admin on August 25, 2020, 10:17:59 PM

Title: WHO "Solidarity" and UK "Recovery" Clinical Trials of HCQ used Fatal Doses?
Post by: admin on August 25, 2020, 10:17:59 PM

"WHO "Solidarity" and UK "Recovery" Clinical Trials of Hydroxychloroquine using Potentially Fatal Doses
By Meryl Nass, MD

They administered doses of HCQ that were 6 times greater than is used to successfully treat a COVID-19 patient with the Zelenko Protocol.
https://www.ageofautism.com/2020/06/who-solidarity-and-uk-recovery-clinical-trials-of-hydroxychloroquine-using-potentially-fatal-doses.html

Let alone that the "trials" were done far too late in the progression of the patient's disease, to expect an anti-viral to have much effect.

Title: Re: WHO "Solidarity" and UK "Recovery" Clinical Trials of HCQ used Fatal Doses
Post by: admin on August 25, 2020, 10:24:28 PM

Quote

Below are the drugs being tested in Solidarity:

    Remdesivir
    Hydroxychloroquine
    Lopinavir with Ritonavir
    Lopinavir with Ritonavir plus Interferon beta-1a.

And apparently those trials didn't even include zinc along with the HCQ, which is the main key to its stunning 99% recovery rate in early outpatient treatment, along with azythromycin.